BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Youness RA, Hafez HM, Khallaf E, Assal RA, Abdel Motaal A, Gad MZ. The long noncoding RNA sONE represses triple-negative breast cancer aggressiveness through inducing the expression of miR-34a, miR-15a, miR-16, and let-7a. J Cell Physiol 2019;234:20286-97. [PMID: 30968427 DOI: 10.1002/jcp.28629] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Kashyap D, Sharma R, Goel N, Buttar HS, Garg VK, Pal D, Rajab K, Shaikh A. Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance. Front Genet 2022;13:993687. [PMID: 36685962 DOI: 10.3389/fgene.2022.993687] [Reference Citation Analysis]
2 Shuaib M, Prajapati KS, Gupta S, Kumar S. Natural Steroidal Lactone Induces G1/S Phase Cell Cycle Arrest and Intrinsic Apoptotic Pathway by Up-Regulating Tumor Suppressive miRNA in Triple-Negative Breast Cancer Cells. Metabolites 2022;13. [PMID: 36676955 DOI: 10.3390/metabo13010029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Paul U, Banerjee S. The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer. Mol Biol Rep 2022. [PMID: 35235157 DOI: 10.1007/s11033-022-07288-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 ZeinElAbdeen YA, AbdAlSeed A, Youness RA. Decoding Insulin-Like Growth Factor Signaling Pathway From a Non-coding RNAs Perspective: A Step Towards Precision Oncology in Breast Cancer. J Mammary Gland Biol Neoplasia 2022. [PMID: 35146629 DOI: 10.1007/s10911-022-09511-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Abdel-Latif M, Riad A, Soliman RA, Elkhouly AM, Nafae H, Gad MZ, Motaal AA, Youness RA. MALAT-1/p53/miR-155/miR-146a ceRNA circuit tuned by methoxylated quercitin glycoside alters immunogenic and oncogenic profiles of breast cancer. Mol Cell Biochem 2022. [PMID: 35129780 DOI: 10.1007/s11010-022-04378-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Li M, Jiao Y, Duan C. A dual-emission fluorescence-enhanced probe for hydrogen sulfide and its application in biological imaging. New J Chem 2022;46:10184-90. [DOI: 10.1039/d2nj01195f] [Reference Citation Analysis]
7 Selem NA, Youness RA, Gad MZ. What is beyond LncRNAs in breast cancer: A special focus on colon cancer-associated Transcript-1 (CCAT-1). Noncoding RNA Res 2021;6:174-86. [PMID: 34938928 DOI: 10.1016/j.ncrna.2021.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mahmoud MM, Sanad EF, Elshimy RAA, Hamdy NM. Competitive Endogenous Role of the LINC00511/miR-185-3p Axis and miR-301a-3p From Liquid Biopsy as Molecular Markers for Breast Cancer Diagnosis. Front Oncol 2021;11:749753. [PMID: 34745973 DOI: 10.3389/fonc.2021.749753] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
9 Jin H, Du W, Huang W, Yan J, Tang Q, Chen Y, Zou Z. lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment. Mol Ther Nucleic Acids 2021;25:613-37. [PMID: 34589282 DOI: 10.1016/j.omtn.2021.08.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
10 Ezzeldeen Y, Swidan S, ElMeshad A, Sebak A. Green Synthesized Honokiol Transfersomes Relieve the Immunosuppressive and Stem-Like Cell Characteristics of the Aggressive B16F10 Melanoma. Int J Nanomedicine 2021;16:5693-712. [PMID: 34465990 DOI: 10.2147/IJN.S314472] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Rajagopal T, Talluri S, Venkatabalasubramanian S, Dunna NR. Multifaceted roles of long non-coding RNAs in triple-negative breast cancer: biology and clinical applications. Biochem Soc Trans 2020;48:2791-810. [PMID: 33258920 DOI: 10.1042/BST20200666] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Xu J, Wu KJ, Jia QJ, Ding XF. Roles of miRNA and lncRNA in triple-negative breast cancer. J Zhejiang Univ Sci B 2020;21:673-89. [PMID: 32893525 DOI: 10.1631/jzus.B1900709] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
13 Thakur KK, Kumar A, Banik K, Verma E, Khatoon E, Harsha C, Sethi G, Gupta SC, Kunnumakkara AB. Long noncoding RNAs in triple-negative breast cancer: A new frontier in the regulation of tumorigenesis. J Cell Physiol 2021. [PMID: 34105151 DOI: 10.1002/jcp.30463] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
14 Shen Y, Xu Y, Huang L, Chi Y, Meng L. MiR-205 suppressed the malignant behaviors of breast cancer cells by targeting CLDN11 via modulation of the epithelial-to-mesenchymal transition. Aging (Albany NY) 2021;13:13073-86. [PMID: 33971623 DOI: 10.18632/aging.202988] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
15 El Kilany FH, Youness RA, Assal RA, Gad MZ. miR-744/eNOS/NO axis: A novel target to halt triple negative breast cancer progression. Breast Dis 2021;40:161-9. [PMID: 33749631 DOI: 10.3233/BD-200454] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 A Youness R, Kamel R, A Elkasabgy N, Shao P, A Farag M. Recent Advances in Tannic Acid (Gallotannin) Anticancer Activities and Drug Delivery Systems for Efficacy Improvement; A Comprehensive Review. Molecules 2021;26:1486. [PMID: 33803294 DOI: 10.3390/molecules26051486] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
17 Ghafouri-fard S, Tamizkar KH, Hussen BM, Taheri M. An update on the role of long non-coding RNAs in the pathogenesis of breast cancer. Pathology - Research and Practice 2021;219:153373. [DOI: 10.1016/j.prp.2021.153373] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
18 Zhang Y, Dong X, Wang Y, Wang L, Han G, Jin L, Fan Y, Xu G, Yuan D, Zheng J, Guo X, Gao P. Overexpression of LncRNA BM466146 Predicts Better Prognosis of Breast Cancer. Front Oncol 2020;10:628757. [PMID: 33585256 DOI: 10.3389/fonc.2020.628757] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Nafea H, Youness RA, Abou-Aisha K, Gad MZ. LncRNA HEIH/miR-939-5p interplay modulates triple-negative breast cancer progression through NOS2-induced nitric oxide production. J Cell Physiol 2021;236:5362-72. [PMID: 33368266 DOI: 10.1002/jcp.30234] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
20 Zhang W, Guan X, Tang J. The long non-coding RNA landscape in triple-negative breast cancer. Cell Prolif 2021;54:e12966. [PMID: 33314471 DOI: 10.1111/cpr.12966] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
21 Xu HK, Chen LJ, Zhou SN, Li YF, Xiang C. Multifunctional role of microRNAs in mesenchymal stem cell-derived exosomes in treatment of diseases. World J Stem Cells 2020; 12(11): 1276-1294 [PMID: 33312398 DOI: 10.4252/wjsc.v12.i11.1276] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
22 Abdel-Latif M, Youness RA. Why natural killer cells in triple negative breast cancer? World J Clin Oncol 2020; 11(7): 464-476 [PMID: 32821652 DOI: 10.5306/wjco.v11.i7.464] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
23 Youness RA, Gad AZ, Sanber K, Ahn YJ, Lee GJ, Khallaf E, Hafez HM, Motaal AA, Ahmed N, Gad MZ. Targeting hydrogen sulphide signaling in breast cancer. J Adv Res 2021;27:177-90. [PMID: 33318876 DOI: 10.1016/j.jare.2020.07.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
24 Xu T, Lei T, Li SQ, Mai EH, Ding FH, Niu B. DNAH17-AS1 promotes pancreatic carcinoma by increasing PPME1 expression via inhibition of miR-432-5p. World J Gastroenterol 2020; 26(15): 1745-1757 [PMID: 32351291 DOI: 10.3748/wjg.v26.i15.1745] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
25 Mei J, Hao L, Wang H, Xu R, Liu Y, Zhu Y, Liu C. Systematic characterization of non-coding RNAs in triple-negative breast cancer. Cell Prolif 2020;53:e12801. [PMID: 32249490 DOI: 10.1111/cpr.12801] [Cited by in Crossref: 24] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
26 Wu H, Wei M, Jiang X, Tan J, Xu W, Fan X, Zhang R, Ding C, Zhao F, Shao X, Zhang Z, Shi R, Zhang W, Wu G. lncRNA PVT1 Promotes Tumorigenesis of Colorectal Cancer by Stabilizing miR-16-5p and Interacting with the VEGFA/VEGFR1/AKT Axis. Mol Ther Nucleic Acids 2020;20:438-50. [PMID: 32276209 DOI: 10.1016/j.omtn.2020.03.006] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 14.7] [Reference Citation Analysis]
27 Kim D, Lee J, Kang J, Kim SH, Yoo TK, Oh S, Lee A. Notch1 in Tumor Microvascular Endothelial Cells and Tumoral miR-34a as Prognostic Markers in Locally Advanced Triple-Negative Breast Cancer. J Breast Cancer 2019;22:562-78. [PMID: 31897330 DOI: 10.4048/jbc.2019.22.e56] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
28 Shi SH, Jiang J, Zhang W, Sun L, Li XJ, Li C, Ge QD, Zhuang ZG. A Novel lncRNA HOXC-AS3 Acts as a miR-3922-5p Sponge to Promote Breast Cancer Metastasis. Cancer Invest 2020;38:1-12. [PMID: 31797701 DOI: 10.1080/07357907.2019.1695816] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]